Anti-Depressant Activity of Aqueous Leaf Extract of Pergularia daemia in In-Vivo Animal Models
DOI:
https://doi.org/10.37591/rrjon.v5i3.1012Abstract
The plant leaf of Pergulariadaemia was used for management of depressive state in various traditional system of medicine like Ayurveda, Unani and Siddha. In the absence of substantial pharmacological data, the present study attempts to study the antidepressant activity of Pergulariademia aqueous extract, by using forced swim test and tail suspension test. Animals were grouped into four treatment groups (n=4) and injected with normal saline (control), imipramine-10 mg/kg (Standard drug), Pergulariadaemia aqueous extract 200 and 400 mg/kg (test drug) orally. Duration of immobility was observed for tail suspension test and forced swim test and compared with control (negative control) and imipramine (positive control). The results showed that in both TST and FST, the aqueous extract of Pergulariadaemia at dose of 200 and 400 mg/kg significantly reduced immobility time (p<0.01) in acute studies and further reduced in chronic studies. However, the effect was increased in swimming (P<0.01) and insignificant change in climbing in acute studies and increased in duration of swimming and climbing (P<0.05 and P<0.01) in chronic studies in FST. The aqueous extract of Pergulariadaemia possesses dose dependent antidepressant effect. Current studies confirm the claimed antidepressant activity in selected doses (200 and 400 mg/kg).
Keywords: Antidepressant, Pergulariadaemia, tail suspension test, forced swim test, neurotransmitters
Cite this Article
Iswar Hazarika. Anti-Depressant activity of aqueous leaf extract of Pergularia Daemia in In-Vivo animal models. Research and Reviews: Journal of Neuroscience. 2015; 5(3): 21–26p
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |